{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T20:26:33Z","timestamp":1793391993945,"version":"4.5.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T00:00:00Z","timestamp":1760054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T00:00:00Z","timestamp":1760054400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Wenzhou Department of Science and Technology","award":["Y20220413"],"award-info":[{"award-number":["Y20220413"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pregnancy Childbirth"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Although extensively investigated, the genetic etiology of fetal growth restriction (FGR) has not been fully understood. Previous studies have shown the potential of karyotyping, chromosomal microarray analysis (CMA) and trio-based WES (trio-WES) in prenatal diagnosis, however, there is little knowledge on the comparative effectiveness of these three prenatal genetic tools. The present study aimed to evaluate and compare the effectiveness of karyotyping, CMA and trio-WES for prenatal diagnosis and prognostic evaluation of FGR, in order to identify the optimal genetic diagnostic testing of FGR.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>All clinical data were retrospectively collected from 388 pregnant women that received invasive prenatal diagnosis due to FGR in Wenzhou Central Hospital and Fujian Maternity and Child Health Hospital during the period from April 2015 to August 2024. All fetuses received karyotyping and CMA, and additional trio-WES was performed among 26 pregnancies negative for karyotyping and CMA. The effectiveness of karyotyping, CMA, and trio-WES alone and in combinations was evaluated for diagnosis of chromosomal abnormality in pregnancies with FGR, and the pregnancy outcomes were followed up.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Karyotyping detected a 4.38% (17\/388) chromosomal abnormality rate and CMA detected a 13.4% (52\/388) chromosomal abnormality rate, which resulted in a 9.28% (36\/388)incremental yield above karyotyping. The diagnostic yield of Karyotyping combined with CMA was 13.66% (53\/388). The common microdeletion and microduplication syndromes included 4p16.3.3 microdeletion syndrome, 1q21.2 microduplication syndrome, 16p13.3 microdeletion syndrome and 22q11.21 microduplication syndrome. Trio-WES revealed a high detection rate (30.77%,8\/26) for diagnosis of P\/LP variants, and the growth- and development-related genes included <jats:italic>IGF1R<\/jats:italic>, <jats:italic>GNAS<\/jats:italic>, <jats:italic>COL9A3<\/jats:italic>, <jats:italic>FGD1<\/jats:italic>, <jats:italic>FLNB<\/jats:italic>, <jats:italic>PORCN<\/jats:italic>, <jats:italic>EVC<\/jats:italic>, <jats:italic>OTX2<\/jats:italic> and <jats:italic>GH1<\/jats:italic>. Of all pregnancies with FGR, the proportions of live births, induced labors, natural abortion, perinatal mortality, and percentage of loss to follow-up were 70.62% (274\/388), 19.84% (77\/388), 0.52% (2\/388), 1.80% (7\/388) and 7.22% (28\/388), respectively.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Karyotyping combined with CMA remains the first-tier tool for prenatal genetic diagnosis of pregnancies with FGR, and additional trio-WES may increase the detection of chromosomal abnormality. <jats:italic>IGF1R<\/jats:italic>, <jats:italic>GNAS<\/jats:italic>, <jats:italic>COL9A3<\/jats:italic> and <jats:italic>FGD1<\/jats:italic> may be candidate genes causing FGR.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s12884-025-08164-0","type":"journal-article","created":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T08:39:28Z","timestamp":1760085568000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Detection of chromosomal and gene abnormality with karyotyping, chromosomal microarray analysis and trio-based whole exome sequencing in pregnancies with fetal growth restriction: implications for precise prenatal diagnosis"],"prefix":"10.1186","volume":"25","author":[{"given":"Yangping","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meiying","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meihuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohe","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuna","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Binbin","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohe","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lili","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hailong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,10]]},"reference":[{"issue":"9212","key":"8164_CR1","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1016\/S0140-6736(05)72599-X","volume":"355","author":"D Churchill","year":"2000","unstructured":"Churchill D, Bayliss H, Beevers G. Fetal growth restriction. Lancet. 2000;355(9212):1366\u20137.","journal-title":"Lancet"},{"issue":"5","key":"8164_CR2","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1007\/s00404-017-4341-9","volume":"295","author":"LM Nardozza","year":"2017","unstructured":"Nardozza LM, Caetano AC, Zamarian AC, et al. Fetal growth restriction: current knowledge. Arch Gynecol Obstet. 2017;295(5):1061\u201377.","journal-title":"Arch Gynecol Obstet"},{"issue":"4","key":"8164_CR3","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/S0957-5847(03)00039-8","volume":"13","author":"S Cummingham","year":"2003","unstructured":"Cummingham S, Cameron IT. Consequences of fetal growth restriction during childhood and adult life. Curr Obstet Gynecol. 2003;13(4):212\u20137.","journal-title":"Curr Obstet Gynecol"},{"key":"8164_CR4","doi-asserted-by":"publisher","DOI":"10.1155\/2011\/640715","volume":"2011","author":"JE Bamfo","year":"2011","unstructured":"Bamfo JE, Odibo AO. Diagnosis and management of fetal growth restriction. J Pregnancy. 2011;2011:2011: 640715.","journal-title":"J Pregnancy"},{"issue":"2","key":"8164_CR5","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1097\/00003081-200606000-00006","volume":"49","author":"D Maulik","year":"2006","unstructured":"Maulik D. Fetal growth restriction: the etiology. Clin Obstet Gynecol. 2006;49(2):228\u201335.","journal-title":"Clin Obstet Gynecol"},{"issue":"11","key":"8164_CR6","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1002\/pd.5160","volume":"37","author":"L Sagi-Dain","year":"2017","unstructured":"Sagi-Dain L, Peleg A, Sagi S. Risk for chromosomal aberrations in apparently isolated intrauterine growth restriction: a systematic review. Prenat Diagn. 2017;37(11):1061\u20136.","journal-title":"Prenat Diagn"},{"issue":"1","key":"8164_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000479506","volume":"44","author":"A Borrell","year":"2018","unstructured":"Borrell A, Grande M, Pauta M, et al. Chromosomal microarray analysis in fetuses with growth restriction and normal karyotype: a systematic review and meta-analysis. Fetal Diagn Ther. 2018;44(1):1\u20139.","journal-title":"Fetal Diagn Ther"},{"issue":"1","key":"8164_CR8","doi-asserted-by":"publisher","first-page":"9220","DOI":"10.1038\/s41598-024-59422-8","volume":"14","author":"X Wu","year":"2024","unstructured":"Wu X, He S, Shen Q, et al. Etiologic evaluation and pregnancy outcomes of fetal growth restriction (FGR) associated with structural malformations. Sci Rep. 2024;14(1):9220.","journal-title":"Sci Rep"},{"issue":"6","key":"8164_CR9","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1002\/uog.24862","volume":"59","author":"M Pauta","year":"2022","unstructured":"Pauta M, Martinez-Portilla RJ, Borrell A. Diagnostic yield of exome sequencing in fetuses with multisystem malformations: systematic review and meta-analysis. Ultrasound Obstet Gynecol. 2022;59(6):715\u201322.","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"2","key":"8164_CR10","doi-asserted-by":"publisher","first-page":"e16","DOI":"10.1097\/AOG.0000000000004251","volume":"137","author":"American College of Obstetricians and Gynecologists Committee on Practice Bulletins\u2014Obstetrics","year":"2021","unstructured":"American College of Obstetricians and Gynecologists Committee on Practice Bulletins\u2014Obstetrics, the Society for Maternal-Fetal Medicine Publications Committee. Fetal growth restriction: ACOG practice bulletin, number 227. Obstet Gynecol. 2021;137(2):e16-28.","journal-title":"Obstet Gynecol"},{"issue":"1","key":"8164_CR11","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23010036","volume":"23","author":"BA Nowakowska","year":"2021","unstructured":"Nowakowska BA, Pankiewicz K, Nowacka U, et al. Genetic background of fetal growth restriction. Int J Mol Sci. 2021;23(1):36.","journal-title":"Int J Mol Sci"},{"issue":"1\u20132","key":"8164_CR12","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.rigp.2005.10.001","volume":"6","author":"C Tower","year":"2006","unstructured":"Tower C, Baker P. The genetics of fetal growth restriction: implications for management. Reviews in Gynaecological and Perinatal Practice. 2006;6(1\u20132):99\u2013105.","journal-title":"Reviews in Gynaecological and Perinatal Practice"},{"issue":"1","key":"8164_CR13","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1186\/s12967-022-03373-z","volume":"20","author":"M Cai","year":"2022","unstructured":"Cai M, Lin N, Su L, et al. Fetal growth restriction: associated genetic etiology and pregnancy outcomes in a tertiary referral center. J Transl Med. 2022;20(1):168.","journal-title":"J Transl Med"},{"key":"8164_CR14","doi-asserted-by":"crossref","unstructured":"Moore S, McGowan-Jordan J, Smith AC, etal. Genome Mapping Nomenclature. Cytogenet Genome Res. 2023;163(5-6):236\u201346.","DOI":"10.1159\/000535684"},{"key":"8164_CR15","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.2147\/RMHP.S299806","volume":"14","author":"X Fan","year":"2021","unstructured":"Fan X, Huang H, Lin X, et al. Performance of chromosomal microarray analysis for detection of copy number variations in fetal echogenic bowel. Risk Manag Healthc Policy. 2021;14:1431\u20138.","journal-title":"Risk Manag Healthc Policy"},{"issue":"2","key":"8164_CR16","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1038\/s41436-019-0686-8","volume":"22","author":"ER Riggs","year":"2020","unstructured":"Riggs ER, Andersen EF, Cherry AM, et al. Technical standards for the interpretation and reporting of constitutional copy-number variants: a joint consensus recommendation of the American college of medical genetics and genomics (ACMG) and the clinical genome resource (ClinGen). Genet Med. 2020;22(2):245\u201357.","journal-title":"Genet Med"},{"issue":"5","key":"8164_CR17","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S, Aziz N, Bale S, ACMG Laboratory Quality Assurance Committee, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American college of medical genetics and genomics and the association for molecular pathology. Genet Med. 2015;17(5):405\u201324.","journal-title":"Genet Med"},{"key":"8164_CR18","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/978-1-61779-201-4_13","volume":"767","author":"SE Bates","year":"2011","unstructured":"Bates SE. Classical cytogenetics: karyotyping techniques. Methods Mol Biol. 2011;767:177\u201390.","journal-title":"Methods Mol Biol"},{"issue":"12","key":"8164_CR19","doi-asserted-by":"publisher","DOI":"10.1002\/jcla.23514","volume":"34","author":"M Hao","year":"2020","unstructured":"Hao M, Li L, Zhang H, et al. The difference between karyotype analysis and chromosome microarray for mosaicism of aneuploid chromosomes in prenatal diagnosis. J Clin Lab Anal. 2020;34(12):e23514.","journal-title":"J Clin Lab Anal"},{"issue":"1","key":"8164_CR20","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/s12884-023-05394-y","volume":"23","author":"X Wu","year":"2023","unstructured":"Wu X, He S, Li Y, et al. Fetal genetic findings by chromosomal microarray analysis and karyotyping for fetal growth restriction without structural malformations at a territory referral center: 10-year experience. BMC Pregnancy Childbirth. 2023;23(1):73.","journal-title":"BMC Pregnancy Childbirth"},{"issue":"2","key":"8164_CR21","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1159\/000511475","volume":"48","author":"K Tzadikevitch Geffen","year":"2021","unstructured":"Tzadikevitch Geffen K, Singer A, Maya I, et al. The yield of chromosomal microarray in pregnancies complicated with fetal growth restriction can be predicted according to clinical parameters. Fetal Diagn Ther. 2021;48(2):140\u20138.","journal-title":"Fetal Diagn Ther"},{"issue":"13","key":"8164_CR22","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1002\/pd.5372","volume":"38","author":"S Brun","year":"2018","unstructured":"Brun S, Pennamen P, Mattuizzi A, et al. Interest of chromosomal microarray analysis in the prenatal diagnosis of fetal intrauterine growth restriction. Prenat Diagn. 2018;38(13):1111\u20139.","journal-title":"Prenat Diagn"},{"issue":"7","key":"8164_CR23","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1002\/uog.3884","volume":"28","author":"M Chen","year":"2006","unstructured":"Chen M, Hwu WL, Kuo SJ, et al. Subtelomeric rearrangements and 22q11.2 deletion syndrome in anomalous growth-restricted fetuses with normal or balanced G-banded karyotype. Ultrasound Obstet Gynecol. 2006;28(7):939\u201343.","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"12","key":"8164_CR24","first-page":"1180","volume":"38","author":"Y Cui","year":"2021","unstructured":"Cui Y, Xiao J, Zhao L, et al. Prenatal diagnosis and genetic counseling in 19 cases with 22q11.2 microduplications. Chin J Med Genet. 2021;38(12):1180\u20134.","journal-title":"Chin J Med Genet"},{"issue":"8","key":"8164_CR25","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1016\/j.celrep.2017.04.069","volume":"19","author":"E Campos-Sanchez","year":"2017","unstructured":"Campos-Sanchez E, Deleyto-Seldas N, Dominguez V, et al. Wolf-Hirschhorn syndrome candidate 1 is necessary for correct hematopoietic and B cell development. Cell Rep. 2017;19(8):1586\u2013601.","journal-title":"Cell Rep"},{"issue":"2","key":"8164_CR26","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1080\/13816810.2017.1408850","volume":"39","author":"MH Ali","year":"2018","unstructured":"Ali MH, Azar NF, Aakalu V, et al. Congenital cavitary optic disc anomaly and Axenfeld\u2019s anomaly in Wolf-Hirschhorn syndrome: a case report and review of the literature. Ophthalmic Genet. 2018;39(2):271\u20134.","journal-title":"Ophthalmic Genet"},{"key":"8164_CR27","doi-asserted-by":"publisher","first-page":"14001","DOI":"10.1038\/hgv.2014.1","volume":"1","author":"T Yamamoto","year":"2014","unstructured":"Yamamoto T, Shimojima K, Shimada S, et al. Clinical impacts of genomic copy number gains at Xq28. Hum Genome Var. 2014;1:14001.","journal-title":"Hum Genome Var"},{"issue":"3","key":"8164_CR28","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1111\/cge.13565","volume":"96","author":"L Sinibaldi","year":"2019","unstructured":"Sinibaldi L, Parisi V, Lanciotti S, et al. Delineation of midXq28-duplication syndrome distal to MECP2 and proximal to RAB39B genes. Clin Genet. 2019;96(3):246\u201353.","journal-title":"Clin Genet"},{"issue":"1","key":"8164_CR29","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1159\/000444596","volume":"7","author":"M Fukami","year":"2016","unstructured":"Fukami M, Seki A, Ogata T. SHOX haploinsufficiency as a cause of syndromic and nonsyndromic short stature. Mol Syndromol. 2016;7(1):3\u201311.","journal-title":"Mol Syndromol"},{"issue":"41","key":"8164_CR30","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000035471","volume":"102","author":"L Liu","year":"2023","unstructured":"Liu L, Li J, Li J, et al. Novel heterozygous mutation in the SHOX gene leading to familial idiopathic short stature: a case report and literature review. Medicine (Baltimore). 2023;102(41):e35471.","journal-title":"Medicine (Baltimore)"},{"issue":"5","key":"8164_CR31","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1093\/humupd\/dmab009","volume":"27","author":"GM Eggenhuizen","year":"2021","unstructured":"Eggenhuizen GM, Go A, Koster MPH, et al. Confined placental mosaicism and the association with pregnancy outcome and fetal growth: a review of the literature. Hum Reprod Update. 2021;27(5):885\u2013903.","journal-title":"Hum Reprod Update"},{"issue":"4","key":"8164_CR32","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1002\/pd.5223","volume":"38","author":"N Brison","year":"2018","unstructured":"Brison N, Neofytou M, Dehaspe L, et al. Predicting fetoplacental chromosomal mosaicism during non-invasive prenatal testing. Prenat Diagn. 2018;38(4):258\u201366.","journal-title":"Prenat Diagn"},{"issue":"2","key":"8164_CR33","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1038\/s41436-019-0630-y","volume":"22","author":"FR Grati","year":"2020","unstructured":"Grati FR, Ferreira J, Benn P, et al. Outcomes in pregnancies with a confined placental mosaicism and implications for prenatal screening using cell-free DNA. Genet Med. 2020;22(2):309\u201316.","journal-title":"Genet Med"},{"issue":"13","key":"8164_CR34","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1002\/pd.5370","volume":"38","author":"S Grau Madsen","year":"2018","unstructured":"Grau Madsen S, Uldbjerg N, Sunde L, Danish Fetal Medicine Study Group; Danish Clinical Genetics Study Group, et al. Prognosis for pregnancies with trisomy 16 confined to the placenta: A Danish cohort study. Prenat Diagn. 2018;38(13):1103\u201310.","journal-title":"Prenat Diagn"},{"key":"8164_CR35","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2020.620013","volume":"11","author":"L Rieger","year":"2021","unstructured":"Rieger L, O\u2019Connor R. Controlled signaling-insulin-like growth factor receptor endocytosis and presence at intracellular compartments. Front Endocrinol (Lausanne). 2021;11:620013.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"5","key":"8164_CR36","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1159\/000510764","volume":"93","author":"MR Shapiro","year":"2020","unstructured":"Shapiro MR, Foster TP, Perry DJ, et al. A novel mutation in insulin-like growth factor 1 receptor (c.641-2A\u2009>\u2009G) is associated with impaired growth, hypoglycemia, and modified immune phenotypes. Horm Res Paediatr. 2020;93(5):322\u201334.","journal-title":"Horm Res Paediatr"},{"issue":"6","key":"8164_CR37","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1210\/clinem\/dgab060","volume":"106","author":"H J\u00fcppner","year":"2021","unstructured":"J\u00fcppner H. Molecular definition of pseudohypoparathyroidism variants. J Clin Endocrinol Metab. 2021;106(6):1541\u201352.","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"8164_CR38","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1159\/000508985","volume":"93","author":"G Mantovani","year":"2020","unstructured":"Mantovani G, Bastepe M, Monk D, et al. Recommendations for diagnosis and treatment of pseudohypoparathyroidism and related disorders: an updated practical tool for physicians and patients. Horm Res Paediatr. 2020;93(3):182\u201396.","journal-title":"Horm Res Paediatr"},{"issue":"4","key":"8164_CR39","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1086\/302328","volume":"64","author":"P Paassilta","year":"1999","unstructured":"Paassilta P, Lohiniva J, Annunen S, et al. Col9a3: a third locus for multiple epiphyseal dysplasia. Am J Hum Genet. 1999;64(4):1036\u201344.","journal-title":"Am J Hum Genet"},{"issue":"3","key":"8164_CR40","doi-asserted-by":"publisher","first-page":"164","DOI":"10.5435\/JAAOS-D-13-00173","volume":"23","author":"S Anthony","year":"2015","unstructured":"Anthony S, Munk R, Skakun W, et al. Multiple epiphyseal dysplasia. J Am Acad Orthop Surg. 2015;23(3):164\u201372.","journal-title":"J Am Acad Orthop Surg"},{"issue":"5","key":"8164_CR41","doi-asserted-by":"publisher","first-page":"2257","DOI":"10.1007\/s00431-024-05484-9","volume":"183","author":"S Li","year":"2024","unstructured":"Li S, Tian A, Wen Y, et al. FGD1-related Aarskog-Scott syndrome: Identification of four novel variations and a literature review of clinical and molecular aspects. Eur J Pediatr. 2024;183(5):2257\u201372.","journal-title":"Eur J Pediatr."},{"issue":"5","key":"8164_CR42","doi-asserted-by":"publisher","first-page":"2257","DOI":"10.1007\/s00431-024-05484-9","volume":"183","author":"S Li","year":"2024","unstructured":"Li S, Tian A, Wen Y, et al. FGD1-related Aarskog-Scott syndrome: identification of four novel variations and a literature review of clinical and molecular aspects. Eur J Pediatr. 2024;183(5):2257\u201372.","journal-title":"Eur J Pediatr"},{"key":"8164_CR43","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/978-3-319-53889-1_3","volume":"978","author":"E Korzus","year":"2017","unstructured":"Korzus E. Rubinstein-taybi syndrome and epigenetic alterations. Adv Exp Med Biol. 2017;978:39\u201362.","journal-title":"Adv Exp Med Biol"},{"issue":"6","key":"8164_CR44","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1586\/14737159.2015.1039516","volume":"15","author":"M Tetreault","year":"2015","unstructured":"Tetreault M, Bareke E, Nadaf J, et al. Whole-exome sequencing as a diagnostic tool: current challenges and future opportunities. Expert Rev Mol Diagn. 2015;15(6):749\u201360.","journal-title":"Expert Rev Mol Diagn"},{"issue":"9","key":"8164_CR45","doi-asserted-by":"publisher","DOI":"10.3390\/genes13091517","volume":"13","author":"A Emms","year":"2022","unstructured":"Emms A, Castleman J, Allen S, et al. Next generation sequencing after invasive prenatal testing in fetuses with congenital malformations: prenatal or neonatal investigation. Genes. 2022;13(9):1517.","journal-title":"Genes"},{"issue":"4","key":"8164_CR46","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1002\/uog.23652","volume":"58","author":"F Mone","year":"2021","unstructured":"Mone F, Eberhardt RY, Hurles ME, et al. Fetal hydrops and the incremental yield of next-generation sequencing over standard prenatal diagnostic testing (FIND) study: prospective cohort study and meta-analysis. Ultrasound Obstet Gynecol. 2021;58(4):509\u201318.","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"5","key":"8164_CR47","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1002\/pd.6339","volume":"43","author":"M Pauta","year":"2023","unstructured":"Pauta M, Martinez-Portilla RJ, Meler E, et al. Diagnostic yield of exome sequencing in isolated fetal growth restriction: systematic review and meta-analysis. Prenat Diagn. 2023;43(5):596\u2013604.","journal-title":"Prenat Diagn"},{"issue":"1","key":"8164_CR48","doi-asserted-by":"publisher","DOI":"10.1080\/07853890.2025.2476038","volume":"57","author":"X Shi","year":"2025","unstructured":"Shi X, Huang Y, Ding H, et al. Utility of whole exome sequencing in the evaluation of isolated fetal growth restriction in normal chromosomal microarray analysis. Ann Med. 2025;57(1):2476038.","journal-title":"Ann Med"},{"issue":"12","key":"8164_CR49","first-page":"33","volume":"18","author":"YL Chen","year":"2024","unstructured":"Chen YL, Liu SY, Xu JJ. Change trend and cause analysis of perinatal mortality from 2013 to 2022. Chin J Mod Drug Appl. 2024;18(12):33\u20136.","journal-title":"Chin J Mod Drug Appl"},{"issue":"4","key":"8164_CR50","first-page":"29","volume":"14","author":"MK Xie","year":"2022","unstructured":"Xie MK, Li GX. Safety strategy to reduce the perinatal mortality. Chin J Fam Plan Gynecotokol. 2022;14(4):29\u20133135.","journal-title":"Chin J Fam Plan Gynecotokol"}],"container-title":["BMC Pregnancy and Childbirth"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-025-08164-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12884-025-08164-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-025-08164-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T14:18:38Z","timestamp":1760365118000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpregnancychildbirth.biomedcentral.com\/articles\/10.1186\/s12884-025-08164-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,10]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["8164"],"URL":"https:\/\/doi.org\/10.1186\/s12884-025-08164-0","relation":{},"ISSN":["1471-2393"],"issn-type":[{"value":"1471-2393","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,10]]},"assertion":[{"value":"23 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Review Committee of Fujian Maternity and Child Health Hospital (approval number: 2021KRD09001) and Wenzhou Central Hospital (approval number: 2022-090), and all pregnant women received genetic counseling and signed the written informed consent prior to invasive prenatal diagnosis. All procedures performed in this study were conducted following the Declaration of Helsinki and international and national laws, regulations and guidelines for ethical review of studies involving humans.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1067"}}